Suspended NA INTERVENTIONAL 3-arm NCT06505993

Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia (K-VAC)

COVID19 -- Health Communication and Structural Intervention Evaluation -- K-VAC: Kentucky Vaccinating All Communities

Sponsor: Marc Kiviniemi

Interventions Health Communication Health Communication + Structural

Updated 4 times since 2024 Last updated: Feb 17, 2026 Started: Sep 30, 2026 Primary completion: Sep 30, 2027 Completion: Sep 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

Potential study redesign

A NA clinical study on COVID-19 and Vaccine Hesitancy, this trial is suspended. The trial is conducted by Marc Kiviniemi and has accumulated 4 data snapshots since 2026. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

4 versions recorded

Feb 2026 — Present [monthly]

Suspended NA

Status: Enrolling By Invitation → Suspended
Oct 2025 — Feb 2026 [monthly]

Enrolling By Invitation NA
Sep 2024 — Oct 2025 [monthly]

Enrolling By Invitation NA
Aug 2024 — Sep 2024 [monthly]

Enrolling By Invitation NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Marc Kiviniemi
National Institute on Minority Health and Health Disparities (NIMHD)

Data source: University of Kentucky

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hazard, United States